NO884175D0 - Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.

Info

Publication number
NO884175D0
NO884175D0 NO884175A NO884175A NO884175D0 NO 884175 D0 NO884175 D0 NO 884175D0 NO 884175 A NO884175 A NO 884175A NO 884175 A NO884175 A NO 884175A NO 884175 D0 NO884175 D0 NO 884175D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
heterocyclic derivatives
therapeutic active
active heterocyclic
Prior art date
Application number
NO884175A
Other languages
English (en)
Other versions
NO884175L (no
Inventor
Massimo Nicola
Enzo Cereda
Giovanbattista Schiavi
Arturo Donetti
Marco Turconi
Rosamaria Micheletti
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Publication of NO884175D0 publication Critical patent/NO884175D0/no
Publication of NO884175L publication Critical patent/NO884175L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/48Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
NO88884175A 1987-09-21 1988-09-20 Fremgangsmaate for fremstilling av terapeutiske aktive heterocykliske derivater. NO884175L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8721976A IT1231237B (it) 1987-09-21 1987-09-21 Derivati eterociclici

Publications (2)

Publication Number Publication Date
NO884175D0 true NO884175D0 (no) 1988-09-20
NO884175L NO884175L (no) 1989-03-22

Family

ID=11189654

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884175A NO884175L (no) 1987-09-21 1988-09-20 Fremgangsmaate for fremstilling av terapeutiske aktive heterocykliske derivater.

Country Status (16)

Country Link
US (1) US4973592A (no)
EP (1) EP0309425A3 (no)
JP (1) JPH01128970A (no)
KR (1) KR890005063A (no)
AU (1) AU2237788A (no)
DD (1) DD282457A5 (no)
DK (1) DK522888A (no)
FI (1) FI884303A (no)
HU (1) HUT56553A (no)
IT (1) IT1231237B (no)
NO (1) NO884175L (no)
PL (5) PL279345A1 (no)
PT (2) PT88545B (no)
SU (1) SU1676446A3 (no)
YU (1) YU177288A (no)
ZA (1) ZA887002B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983604A (en) * 1987-11-13 1991-01-08 The Rockefeller University Inhibitors of nonenzymatic cross-linking
CA2027530C (en) * 1989-10-20 2001-05-08 Jules Freedman W-phenoxy-heterocyclic compounds
DE4142190A1 (de) * 1991-12-20 1993-06-24 Bayer Ag Verfahren zur herstellung von optisch aktiven (alpha)-hydroxycarbonsaeuren
ZA931109B (en) * 1992-03-04 1993-09-22 Akzo Nv Tetrahydropyrimidine derivatives.
USRE38952E1 (en) 1994-03-08 2006-01-31 Hale Nathan S Heat activated ink jet ink
CA2303385A1 (en) * 1997-09-18 1999-03-25 Mitsubishi-Tokyo Pharmaceuticals, Inc. Imidazoline compounds
US6384461B1 (en) * 1999-10-15 2002-05-07 Xerox Corporation Dual dielectric structure for suppressing lateral leakage current in high fill factor arrays
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
DE60045082D1 (de) * 2000-06-07 2010-11-18 Watson Pharmaceuticals Inc Behandlung von überaktivität glatter muskulatur mit (r)-oxybutynin und (r)-desethyloxybutynin
US6818659B2 (en) * 2001-11-06 2004-11-16 Bristol-Myers Squibb Pharma, Inc. (2S)-2-amino-4-(2-amino-(3,4,5,6-tetrahydropyrimidin-4-yl) butanoyl and its use in cyclic and acyclic peptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126381A (en) * 1964-03-24 Cghschzcooh
GB593659A (en) * 1945-06-19 1947-10-22 Boots Pure Drug Co Ltd Improvements relating to the manufacture of heterocyclic amines
US3205232A (en) * 1961-08-17 1965-09-07 Socony Mobil Oil Co Inc Salts of tetrahydropyrimidines and nu-alkyl succinamic acids
DE1189998B (de) * 1961-11-14 1965-04-01 Basf Ag Verfahren zur Herstellung von cyclischen Formamidinen
US3483203A (en) * 1966-03-22 1969-12-09 Ciba Geigy Corp 2-aralkyl-1,3-diaza-2-cycloalkenes
US3502578A (en) * 1966-06-30 1970-03-24 Shell Oil Co Corrosion inhibiting method and composition therefor
DE1695601A1 (de) * 1968-02-08 1972-04-13 Pfizer In 2-Stellung der AEthylgruppe substituierte cyclische 2-(ss-Hydroxyaethyl)-amidine und Verfahren zu ihrer Herstellung,sowie Verfahren zur Herstellung von in 2-Stellung der Vinylgruppe substituierten cyclischen 2-Vinylamidinen
DE2154948A1 (de) * 1971-11-05 1973-05-10 Huels Chemische Werke Ag Verfahren zur herstellung von cyclischen amidinen
JPS5936630B2 (ja) * 1976-02-09 1984-09-05 第一製薬株式会社 2−イミノ−1,3−ジアザシクロアルカン誘導体

Also Published As

Publication number Publication date
KR890005063A (ko) 1989-05-11
HUT56553A (en) 1991-09-30
PL274750A1 (en) 1989-09-04
PT88542A (pt) 1989-07-31
PT88545B (pt) 1992-11-30
IT1231237B (it) 1991-11-26
SU1676446A3 (ru) 1991-09-07
YU177288A (en) 1990-06-30
FI884303A (fi) 1989-03-22
DK522888A (da) 1989-03-22
US4973592A (en) 1990-11-27
PL279344A1 (en) 1990-01-08
PL279342A1 (en) 1990-01-08
EP0309425A3 (en) 1990-06-27
DD282457A5 (de) 1990-09-12
PT88545A (pt) 1988-10-01
FI884303A0 (fi) 1988-09-20
DK522888D0 (da) 1988-09-20
PL279343A1 (en) 1990-01-08
JPH01128970A (ja) 1989-05-22
NO884175L (no) 1989-03-22
EP0309425A2 (en) 1989-03-29
ZA887002B (en) 1990-05-30
IT8721976A0 (it) 1987-09-21
PL279345A1 (en) 1990-01-08
AU2237788A (en) 1989-03-23

Similar Documents

Publication Publication Date Title
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO895086L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO853293L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO894630L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO884231D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazopyridin-derivater.
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO875488L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO881762D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater.
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO884176L (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
NO884175L (no) Fremgangsmaate for fremstilling av terapeutiske aktive heterocykliske derivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO881884D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO167739C (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive ginkolid-derivater.
NO890607L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO882201D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.
NO870499D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO883932D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive laktamderivater.